COL1A2 and Myocardial fibrosis: Previous studies have shown that myocardial fibrosis, measured through the level of serum C-terminal pro-peptide of type I procollagen (PICP), was observed in the carriers of pathogenic sarcomere variants in individuals with or without overt cardiomyopathy (2).